103 related articles for article (PubMed ID: 158556)
1. The use of chromogenic substrates for the determination of kallikrein and other serine proteases in plasma and synovial fluid in man.
Lewis DH; Bengtsson MB; Liljedahl SO; Larsson J
Adv Biosci; 1978 Jul; 17():163-71. PubMed ID: 158556
[No Abstract] [Full Text] [Related]
2. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
Friberger P
Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
[No Abstract] [Full Text] [Related]
3. [Function of the prekallikrein-kallikrein system of convalescent burn patients with uncorrected deformities and contractures].
Veremeenko KN; Vasil'chuk IuM; Pogorelaia NF; Sizov VM
Klin Khir (1962); 1987; (3):12-4. PubMed ID: 3553709
[No Abstract] [Full Text] [Related]
4. [Characterization of shock sensitivity in experimental hemorrhagic shock (5,3 and 8,0 kPa) by determining kallikrein, kallikreinogen, non-specific proteases and inhibitor capacity of blood plasma].
Kühne H; Lehmann B; Taucher M; Scheuch DW
Z Med Lab Diagn; 1983; 24(3):123-8. PubMed ID: 6351457
[No Abstract] [Full Text] [Related]
5. [Effect of exogenous histamine on the proteolytic activity, level of proteolysis inhibitors and on the state of the kallikrein-kinin system of the blood].
Bogadel'nikov IV; Protsenko VZ; Spitsyn IF; Kharchenko VZ; Shaevskiĭ DV
Patol Fiziol Eksp Ter; 1979; (1):51-4. PubMed ID: 311464
[No Abstract] [Full Text] [Related]
6. Measuring net protease activities in biological samples using selective peptidic inhibitors.
Pollaro L; Diderich P; Angelini A; Bellotto S; Wegner H; Heinis C
Anal Biochem; 2012 Aug; 427(1):18-20. PubMed ID: 22549049
[TBL] [Abstract][Full Text] [Related]
7. Chromogenic peptide substrate assays for determining components of the plasma kallikrein system.
Gallimore MJ
Scand J Clin Lab Invest Suppl; 1985; 178():127-32. PubMed ID: 3867113
[TBL] [Abstract][Full Text] [Related]
8. Treatment of sepsis in the surgical patient evaluated by means of chromogenic peptide substrate assays.
Smith-Erichsen N; Aasen AO; Amundsen E
Acta Chir Scand Suppl; 1982; 509():33-8. PubMed ID: 6187146
[TBL] [Abstract][Full Text] [Related]
9. Neutral proteases from granulocytes and their inhibitors.
Wendt P; Blümel G
Adv Biosci; 1978 Jul; 17():73-81. PubMed ID: 226431
[No Abstract] [Full Text] [Related]
10. Circulating levels of prekallikrein and kallikrein in pregnancy and labor.
Sayama S; Kashiwagi H; Ogawa T; Terada K; Soma H; Kato M
Int J Biol Res Pregnancy; 1981; 2(2):90-4. PubMed ID: 6916725
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a microassay for human plasma prekallikrein.
De La Cadena RA; Scott CF; Colman RW
J Lab Clin Med; 1987 May; 109(5):601-7. PubMed ID: 3646287
[TBL] [Abstract][Full Text] [Related]
12. A novel chromogenic peptide for prekallikrein/kallikrein determination.
Huang WY; Wan X; Zhang S
Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
[TBL] [Abstract][Full Text] [Related]
13. Plasma kallikrein activity and prekallikrein levels during endotoxin shock in dogs.
Aasen AO; Frolich W; Saugstad OD; Amundsen E
Eur Surg Res; 1978; 10(1):50-62. PubMed ID: 344043
[TBL] [Abstract][Full Text] [Related]
14. [The use of a tripeptide chromogenic substrate for simultaneous determination of 4 indices of kallikrein-kinin system].
Dotsenko VL; Iarovaia GA; Neshkova EA
Vopr Med Khim; 1989; 35(2):128-33. PubMed ID: 2741408
[TBL] [Abstract][Full Text] [Related]
15. Septic shock in the rat: activation of plasma proteolytic systems and effects of a kallikrein inhibitor/bradykinin antagonist (S-2441).
Högström H; Claeson G; Larsson-Backström C; Lundberg D; Wenngren E; Haglund U
Acta Chir Scand; 1987 Mar; 153(3):161-4. PubMed ID: 3300117
[TBL] [Abstract][Full Text] [Related]
16. Methodological considerations on chromogenic peptide substrate assays and application on automated analyzers.
Aasen AO; Kierulf P; Strømme JH
Acta Chir Scand Suppl; 1982; 509():17-22. PubMed ID: 6187145
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein and prekallikrein determination in a number of pathological conditions using the Centrifichem analyzer.
Creter D; Allalouf D
Ann Allergy; 1982 Jun; 48(6):349-50. PubMed ID: 6920247
[TBL] [Abstract][Full Text] [Related]
18. [Determination of plasma kallikrein and prekallikrein in patients with epidemic hemorrhagic fever and its clinical significance].
Tong MQ
Zhonghua Yi Xue Za Zhi; 1987 May; 67(5):256-7. PubMed ID: 2888524
[No Abstract] [Full Text] [Related]
19. Purification and some properties of collagenase proenzyme activator from rheumatoid synovial fluid.
Kruze D; Salgam P; Cohen G; Fehr K; Böni A
Z Rheumatol; 1978; 37(11-12):355-65. PubMed ID: 216183
[TBL] [Abstract][Full Text] [Related]
20. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
Alving BM; Tankersley DL; Mason BL
J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
